DVN and FANG are both operators in the oil and gas industry, having a strong presence in the domestic market.

INTC slumps after Q2 miss despite strong guidance. ETFs like FEPI, VLUE, SOXX and SOXQ are most exposed to the chipmaker's next move.

Granite Ridge Resources offers a 8.2% yield, low overhead, and a strong hedging program, making it attractive for income-focused investors despite recent volatility. The company's diversified, data-driven investment approach and focus on the Permian Basin support stable cash flow and regular dividends. Concerns about rising debt are mitigated by conservative leverage, robust liquidity, and management's focus on growth and efficiency, not just dividend payments.

@ProsperTradingAcademy's Charles Moon turns to three names he sees making notable recoveries in their stock price. He talks about the "great upside" Okta Inc. (OKTA) holds, Eli Lilly's (LLY) "technical breakout," and Autodesk's (ADSK) path to reclaim its 52-week high.

Key Points in This Article: The stock market is rising despite growing risks, including falling durable goods orders, uneven earnings, upcoming tech reports, global tensions, and political friction, signaling potential volatility.

LOS ANGELES, July 25, 2025 (GLOBE NEWSWIRE) -- Glancy Prongay & Murray LLP reminds investors of the upcoming August 11, 2025 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired Rocket Pharmaceuticals, Inc. (“Rocket” or the “Company”) (NASDAQ: RCKT) securities between September 17, 2024 and May 26, 2025, inclusive (the “Class Period”).

LOS ANGELES , July 25, 2025 /PRNewswire/ -- Glancy Prongay & Murray LLP announces that investors with losses have opportunity to lead the securities fraud class action lawsuit against Vestis Corporation ("Vestis" or the "Company") (NYSE: VSTS). IF YOU SUFFERED A LOSS ON YOUR VESTIS INVESTMENTS, CLICK HERE BEFORE AUGUST 8, 2025 (LEAD PLAINTIFF DEADLINE) TO PARTICIPATE IN THE SECURITIES FRAUD LAWSUIT What Is The Lawsuit About?

LOS ANGELES , July 25, 2025 /PRNewswire/ -- The Law Offices of Frank R. Cruz announces that investors with losses related to Fortrea Holdings Inc. ("Fortrea" or the "Company") (NASDAQ: FTRE) have opportunity to lead the securities fraud class action lawsuit.

BENSALEM, Pa., July 25, 2025 (GLOBE NEWSWIRE) -- Law Offices of Howard G. Smith reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies. Investors have until the deadlines listed below to file a lead plaintiff motion.

PORTLAND, Maine, July 25, 2025 (GLOBE NEWSWIRE) -- Northeast Bank (the “Bank”) (NASDAQ: NBN), a Maine-based bank, announced today that the Bank will host a conference call with a simultaneous webcast at 1:00 p.m. ET on Tuesday, July 29, 2025 to discuss the Bank's fiscal 2025 fourth quarter earnings. This conference call was previously announced as occurring on July 31, 2025. The conference call will be hosted by Rick Wayne, President and Chief Executive Officer, Richard Cohen, Chief Financial Officer, and Pat Dignan, Chief Operating Officer.

LOS ANGELES, July 25, 2025 (GLOBE NEWSWIRE) -- Glancy Prongay & Murray LLP reminds investors of the upcoming August 12, 2025 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired Tempus AI, Inc. (“Tempus” or the “Company”) (NASDAQ: TEM) common stock between August 6, 2024 and May 27, 2025, inclusive (the “Class Period”).

TYLER, Texas, July 25, 2025 (GLOBE NEWSWIRE) -- Southside Bancshares, Inc. (the “Company”) (NYSE:SBSI), parent company of Southside Bank, will ring the opening bell at the New York Stock Exchange on Monday, July 28th to celebrate the 65th anniversary of Southside Bank. Lee R. Gibson, Chief Executive Officer, alongside members of the Company's management team and board of directors, will participate in the ceremonial bell ringing.

LOS ANGELES--(BUSINESS WIRE)--Glancy Prongay & Murray LLP, a leading national shareholder rights law firm, announces that a securities fraud class action lawsuit has been filed on behalf of investors who purchased or otherwise acquired Neogen Corporation (“Neogen” or the “Company”) (NASDAQ: NEOG) common stock between January 5, 2023 through June 3, 2025, inclusive (the “Class Period”). Neogen investors have until September 16, 2025 to file a lead plaintiff motion. IF YOU SUFFERED A LOSS ON.

BENSALEM, Pa.--(BUSINESS WIRE)--Law Offices of Howard G. Smith reminds investors of the upcoming September 22, 2025 deadline to file a lead plaintiff motion in the case filed on behalf of investors who purchased RxSight, Inc. (“RxSight” or the “Company”) (NASDAQ: RXST) securities between November 7, 2024 and July 8, 2025, inclusive (the “Class Period”). IF YOU ARE AN INVESTOR WHO SUFFERED A LOSS IN RXSIGHT, INC. (RXST), CONTACT THE LAW OFFICES OF HOWARD G. SMITH TO PARTICIPATE IN THE ONGOING SE.

LOS ANGELES--(BUSINESS WIRE)--Hope Bancorp, Inc. (NASDAQ: HOPE) today announced that executive management will be participating in the 26th Annual KBW Community Bank Investor Conference in New York City, July 29, 2025. A copy of the investor presentation being used for meetings with institutional investors will be available in the Investor Relations section of the Company's website at www.ir-hopebancorp.com effective July 25, 2025. About Hope Bancorp, Inc. Hope Bancorp, Inc. (NASDAQ: HOPE) is t.

BENSALEM, Pa., July 25, 2025 /PRNewswire/ -- The Law Offices of Howard G. Smith announces that investors with substantial losses have opportunity to lead the securities fraud class action lawsuit against Reddit, Inc. ("Reddit" or the "Company") (NYSE: RDDT).

The last week in the gold market saw a lot of selling pressures, and with this, the market continues to see a lot of questions asked of whether or not we can finally break out of the consolidation range that is so obvious at this point.

Edelson Lechtzin LLP is investigating securities fraud claims on behalf of purchasers of RxSight, Inc. (NASDAQ: RXST) between Nov. 7, 2024 & July 8, 2025

TransMedics beat Q1 2025 estimates and raised full-year guidance, showing strong revenue and earnings growth. The company holds a unique market position with the only FDA-approved system for heart, lung, and liver transport. Profitability and margins are improving, though free cash flow, dilution, and a limited TAM remain concerns.

GRMN's second-quarter 2025 earnings are expected to be fueled by demand across fitness, outdoor, marine, aviation and auto segments.